• Biospecimen SolutionsPrecision Value & HealthCareers
    P_ForMedicine_no_tag_RGBP_ForMedicine_no_tag_RGBP_ForMedicine_no_tag_RGBP_ForMedicine_no_tag_RGB
    • Clinical
      Trial Services
        • Overview
            • Oncology Clinical TrialsImage

              Oncology Clinical Trials


              Through 20+ years running successful oncology trials, we’ve developed a unique blend of proprietary technologies, flexible processes, and creative problem solving abilities that advance even the most challenging clinical development programs.

              • Rare & Orphan DiseaseImage

                Rare & Orphan Disease


                With experience built on 150+ orphan disease projects covering 80+ rare diseases, we know how to anticipate logistical and regulatory obstacles and craft bold solutions that drive rare disease development programs.

        • Global Clinical Trial Support
            • North & South America
              • Oncology Clinical TrialsImage

                Oncology Clinical Trials


                Through 20+ years running successful oncology trials, we’ve developed a unique blend of proprietary technologies, flexible processes, and creative problem solving abilities that advance even the most challenging clinical development programs.

            • Europe
              • Oncology Clinical TrialsImage

                Oncology Clinical Trials


                Through 20+ years running successful oncology trials, we’ve developed a unique blend of proprietary technologies, flexible processes, and creative problem solving abilities that advance even the most challenging clinical development programs.

            • APAC
              • Oncology Clinical TrialsImage

                Oncology Clinical Trials


                Through 20+ years running successful oncology trials, we’ve developed a unique blend of proprietary technologies, flexible processes, and creative problem solving abilities that advance even the most challenging clinical development programs.

        • Clinical Trial Management
            • Study Start-up & Feasibility
              • Oncology Clinical TrialsImage

                Oncology Clinical Trials


                Through 20+ years running successful oncology trials, we’ve developed a unique blend of proprietary technologies, flexible processes, and creative problem solving abilities that advance even the most challenging clinical development programs.

            • Project Management
            • Patient Recruitment
            • Personalized Clinical Trial Operations
            • Biometrics
            • Medical & Safety Monitoring
            • Clinical Data Management
            • Medical Writing
        • Clinical Development Strategy
            • Clinical Development Planning
              • Oncology Clinical TrialsImage

                Oncology Clinical Trials


                Through 20+ years running successful oncology trials, we’ve developed a unique blend of proprietary technologies, flexible processes, and creative problem solving abilities that advance even the most challenging clinical development programs.

            • Biomarker Strategies
            • Cell & Gene Therapy Strategies
            • CDx Regulatory and Market Access
        • Clinical Trial Design
            • Basket & Umbrella Trials
              • Oncology Clinical TrialsImage

                Oncology Clinical Trials


                Through 20+ years running successful oncology trials, we’ve developed a unique blend of proprietary technologies, flexible processes, and creative problem solving abilities that advance even the most challenging clinical development programs.

            • Biomarker Clinical Trials
            • Master Protocol Trials
            • Decentralized Clinical Trials
        • Biostatistics
            • Statistical Consulting
              • Oncology Clinical TrialsImage

                Oncology Clinical Trials


                Through 20+ years running successful oncology trials, we’ve developed a unique blend of proprietary technologies, flexible processes, and creative problem solving abilities that advance even the most challenging clinical development programs.

            • Study Design
            • Data Monitoring Committees
            • CDISC Programming and Documentation
            • eCTD Submissions
        • Central Lab Services
            • Clinical Specimen Kitting
              • Oncology Clinical TrialsImage

                Oncology Clinical Trials


                Through 20+ years running successful oncology trials, we’ve developed a unique blend of proprietary technologies, flexible processes, and creative problem solving abilities that advance even the most challenging clinical development programs.

            • Sample Processing
            • Global Specimen Logistics and Biostorage
            • Biospecimen Data Services
            • Precision Lab e-Portal
            • Virtual Sample Inventory Management
        • Training
            • Oncology Clinical TrialsImage

              Oncology Clinical Trials


              Through 20+ years running successful oncology trials, we’ve developed a unique blend of proprietary technologies, flexible processes, and creative problem solving abilities that advance even the most challenging clinical development programs.

              • Rare & Orphan DiseaseImage

                Rare & Orphan Disease


                With experience built on 150+ orphan disease projects covering 80+ rare diseases, we know how to anticipate logistical and regulatory obstacles and craft bold solutions that drive rare disease development programs.

    • Lab
      Services
        • Central Lab Services
            • Clinical Specimen Kitting
              • Oncology Clinical TrialsImage

                Oncology Clinical Trials


                Through 20+ years running successful oncology trials, we’ve developed a unique blend of proprietary technologies, flexible processes, and creative problem solving abilities that advance even the most challenging clinical development programs.

            • Sample Processing
            • Global Specimen Logistics and Biostorage
            • Biospecimen Data Services
            • Precision Lab e-Portal
            • Virtual Sample Inventory Management
        • Specialty Lab Services Overview
            • Immune MonitoringImage

              Immune Monitoring


              Leverage sophisticated immune monitoring approaches, including flow cytometry, Epiontis ID immune cell phenotyping, and cytokine profiling, to characterize the immune cells in your samples and understand their impact on patient biology.

              • Tissue & Liquid BiopsyImage

                Tissue and Liquid Biopsy


                Obtain a detailed molecular view into patient biology with a range of tissue and liquid biopsy technologies, including our proprietary ApoStream platform which can isolate and enrich circulating tumor cells for downstream analysis.

        • EU Contract Research Organization
        • Immune Monitoring
            • Immune Monitoring by Flow Cytometry
              • Immune MonitoringImage

                Immune Monitoring


                Leverage sophisticated immune monitoring approaches, including flow cytometry, Epiontis ID immune cell phenotyping, and cytokine profiling, to characterize the immune cells in your samples and understand their impact on patient biology.

            • Immune Cell Phenotyping by Epiontis ID
            • Cytokine Profiling
            • Gene Expression Profiling
            • ELISpot and FluoroSpot
            • Custom Assays
        • Flow Cytometry
            • Receptor Occupancy Assays by Flow Cytometry
              • Immune MonitoringImage

                Immune Monitoring


                Leverage sophisticated immune monitoring approaches, including flow cytometry, Epiontis ID immune cell phenotyping, and cytokine profiling, to characterize the immune cells in your samples and understand their impact on patient biology.

        • Genomics
            • NanoString Assays
              • Immune MonitoringImage

                Immune Monitoring


                Leverage sophisticated immune monitoring approaches, including flow cytometry, Epiontis ID immune cell phenotyping, and cytokine profiling, to characterize the immune cells in your samples and understand their impact on patient biology.

            • ddPCR
            • qPCR
            • NGS
            • Fluorescence In Situ Hybridisation (FISH) / ISH
        • Tissue & Liquid Biopsy
            • ApoStream – CTC and Rare Cell Isolation for Liquid Biopsy
              • Immune MonitoringImage

                Immune Monitoring


                Leverage sophisticated immune monitoring approaches, including flow cytometry, Epiontis ID immune cell phenotyping, and cytokine profiling, to characterize the immune cells in your samples and understand their impact on patient biology.

            • CTC / cfDNA / Exosome Analysis
            • Multiplex Immunofluorescence
            • Immunohistochemistry
            • Fluorescence In Situ Hybridisation (FISH) / ISH
            • Pathology Services
            • NanoString Assays
        • Bioanalytical Testing
            • Immunogenicity Testing
              • Immune MonitoringImage

                Immune Monitoring


                Leverage sophisticated immune monitoring approaches, including flow cytometry, Epiontis ID immune cell phenotyping, and cytokine profiling, to characterize the immune cells in your samples and understand their impact on patient biology.

            • PK Assays
            • ADA Assays
            • MesoScale Discovery (MSD) Assays
            • Quanterix SIMOA
            • ELISA
        • Protein & Cytokine Analysis
            • ELISA
              • Immune MonitoringImage

                Immune Monitoring


                Leverage sophisticated immune monitoring approaches, including flow cytometry, Epiontis ID immune cell phenotyping, and cytokine profiling, to characterize the immune cells in your samples and understand their impact on patient biology.

            • MesoScale Discovery (MSD) Assays
            • Luminex
            • Quanterix SIMOA
            • Automated Western Blotting
        • Preclinical Target and Biomarker Validation
            • Cell Based Assays
            • Target Expression – XpressWay Profiles
            • Tissue Cross-Reactivity
            • Fluorescence In Situ Hybridisation (FISH) / ISH
            • Multiplex Immunofluorescence
            • Immunohistochemistry (IHC)
        • Biospecimens
            • Immune MonitoringImage

              Immune Monitoring


              Leverage sophisticated immune monitoring approaches, including flow cytometry, Epiontis ID immune cell phenotyping, and cytokine profiling, to characterize the immune cells in your samples and understand their impact on patient biology.

              • Tissue & Liquid BiopsyImage

                Tissue and Liquid Biopsy


                Obtain a detailed molecular view into patient biology with a range of tissue and liquid biopsy technologies, including our proprietary ApoStream platform which can isolate and enrich circulating tumor cells for downstream analysis.

    • Data
      Sciences
        • Overview
            • BiostatisticsImage

              Biostatistics


              Seasoned biostatisticians and statistical programmers support every phase of your trial, from study design for small, rare disease trials to regulatory submissions, all backed by meticulous documentation.

              • QuartzBioImage

                QuartzBio® Solutions


                Purpose-built SaaS solutions developed to address the complex, manual, and siloed processes that exist in sample and biomarker data management by delivering innovative data-enabling technologies in a single, scalable platform.

        • Biostatistics
        • Clinical Data Management
        • Biometrics
        • QuartzBio® Solutions
            • enterprise Biomarker Data Management (eBDM)
              • BiostatisticsImage

                Biostatistics


                Seasoned biostatisticians and statistical programmers support every phase of your trial, from study design for small, rare disease trials to regulatory submissions, all backed by meticulous documentation.

            • virtual Sample Inventory Management (vSIM)
            • Analytics, Information, Insights, and Reporting
    • Diagnostics
      & CDx
        • IVD and CDx Regulatory Affairs Consulting
          • spevialty_labs_slice-300×54Image

            Specialty Lab Services


            Our comprehensive approach starts with a foundation of expertise in key biomaker discovery and analysis methods such as immune monitoring, genomics, and bioanalysis.

        • COVID-19 & Viral Panel Assays
          • spevialty_labs_slice-300×54Image

            Specialty Lab Services


            Our comprehensive approach starts with a foundation of expertise in key biomaker discovery and analysis methods such as immune monitoring, genomics, and bioanalysis.

        • Biospecimens Solutions 
          • spevialty_labs_slice-300×54Image

            Specialty Lab Services


            Our comprehensive approach starts with a foundation of expertise in key biomaker discovery and analysis methods such as immune monitoring, genomics, and bioanalysis.

        • Diagnostic Market Access Services
          • spevialty_labs_slice-300×54Image

            Specialty Lab Services


            Our comprehensive approach starts with a foundation of expertise in key biomaker discovery and analysis methods such as immune monitoring, genomics, and bioanalysis.

        • Companion Diagnostics
    • Therapeutic
      Areas
        • Overview
            • By Specialty Area
              • Global-clinical-trial-support-2Image

                Global Clinical Trial Support


                Sample processing labs, clinical trial sites and offices in five continents provide the clinical reach and scale to manage complex global programs.

            • Oncology and Immuno-Oncology
              • Oncology Clinical Trials
            • Rare & Orphan Disease
              • Global-clinical-trial-support-2Image

                Global Clinical Trial Support


                Sample processing labs, clinical trial sites and offices in five continents provide the clinical reach and scale to manage complex global programs.

            • Cell & Gene Therapy
              • Cell Therapy
              • Gene Therapy
              • Cell and Gene Therapy Manufacturing
            • CNS & Neuroscience
              • Global-clinical-trial-support-2Image

                Global Clinical Trial Support


                Sample processing labs, clinical trial sites and offices in five continents provide the clinical reach and scale to manage complex global programs.

            • COVID-19
            • AutoImmune & Allergy
            • Pediatric
        • By Research Phase
        • Preclinical Development
        • Early Phase Trials (I-IIa)
        • Late Phase Trials (IIb-III)
    • News &
      Insights
        • Blog
            • iStock-945738094Image

              Blog


              Industry trends and best practices from Precision experts

              • shutterstock_1033743346Image

                Resources


                A searchable hub featuring the latest Precision case studies, white papers, capabilities brochures and more.

        • Resources
        • Thought Leadership
        • News
            • iStock-945738094Image

              Blog


              Industry trends and best practices from Precision experts

              • shutterstock_1033743346Image

                Resources


                A searchable hub featuring the latest Precision case studies, white papers, capabilities brochures and more.

        • Events
            • iStock-945738094Image

              Blog


              Industry trends and best practices from Precision experts

              • shutterstock_1033743346Image

                Resources


                A searchable hub featuring the latest Precision case studies, white papers, capabilities brochures and more.

    • About
      Us
        • Our Passion
            • Patient RecruitmentImage

              Our Passion


              What we do, why we do it and the principles that guide us every day.

              • meet-our-peopleImage

                Meet Our People


                We are devoted professionals with deep expertise in translational science, clinical trials and data sciences.

        • Meet Our People
        • Careers
        • Regulatory Information
            • Patient RecruitmentImage

              Our Passion


              What we do, why we do it and the principles that guide us every day.

              • meet-our-peopleImage

                Meet Our People


                We are devoted professionals with deep expertise in translational science, clinical trials and data sciences.

    • Contact
      Us
    ✕
    • Home
    • Harnessing the Power of Flow Cytometry in Biomarker-Driven Clinical Trials
    Blog Clinical Research Insights Translational & Lab Insights
    Article

    Harnessing the Power of Flow Cytometry in Biomarker-Driven Clinical Trials

    Written By Laura Lozzo, PhD
    April 19, 2023 • 5 min. read

    Flow cytometry has become invaluable in biomarker-driven clinical trials due to its multiparametric nature, which can provide highly detailed information on any single cell in a heterogeneous population. Because of its versatility, flow cytometry is the primary method used to monitor immune responses in both the preclinical and clinical settings, allowing researchers to visualize immune cells and their interactions in disease or after drug treatment, thereby facilitating biomarker discovery and validation and guiding clinical decisions.

    Advantages and Key Benefits of Flow Cytometry

    Advantages of flow cytometry over other cell analysis methods include:

    • High throughput: Flow cytometers can measure >35,000 events per second, allowing researchers to narrow down the biomarker profile and the targeted cell population, accelerating drug development.
    • Multiparameter: Current technology can measure >40 fluorophores simultaneously. Surface, intracellular, and intranuclear information can be analyzed at the single-cell level.
    • Comprehensiveness: Researchers can obtain information on the heterogeneity and cell differentiation of the immune cell subsets, phenotype, activation, and proliferation.
    • Quantification: In addition to providing relative percentages, flow cytometry can provide absolute count and number of receptors in a cell.
    • Ability to quantify receptor occupancy: Flow cytometry-based receptor occupancy assays quantify the occupancy of drug-target receptors by measuring the levels of free and occupied receptors after drug treatment and at the single-cell level.
    Figure 1. Flow cytometry enables analysis of surface, intracellular, and intranuclear information at the single-cell level

    Applications of Flow Cytometry in Biomarker-Driven Trials

    There are various potential applications for flow cytometry in biomarker-driven clinical trials, a few of which are enumerated below.

    Immunophenotyping to Investigate Immune System Response After Drug Treatment

    Immunophenotyping is valuable when transitioning from preclinical research to early-phase clinical development. For targeted therapies, immunophenotyping can be used to demonstrate that the drug induces the activation or depletion of the target cell population while leaving other cell populations unaffected. Flow cytometry can also help support safety data and dosage information in early-phase clinical studies, for example, by showing how drug treatment affects proinflammatory cytokine production, cell activation, or proliferation. Flow cytometry may even be useful for identifying surrogate biomarkers. For instance, to evaluate the immune response to a drug designed to treat solid tumors, which are difficult to analyze, it may be beneficial to identify downstream hematopoietic biomarkers or evaluate non-specific responses in the periphery.

    Monitoring Receptor Occupancy with Biologics

    Frequently used to generate pharmacodynamic (PD) biomarker data in preclinical and clinical studies, receptor occupancy (RO) assays are designed to quantify binding of therapeutics to cell surface targets. RO is commonly measured by flow cytometry, using one or a combination of three basic formats: free receptor measurement, total receptor measurement, or direct assessment of bound receptor. Since the staining occurs at the single-cell level, the RO is key to determining the saturation and half-maximal active concentration (EC50) of the drug on the target cell population and verifying any collateral effects, such as cleavage or internalization of the receptor, survival of the cells, or activation of unwanted cell populations.

    Figure 2. Basic formats for receptor occupancy (RO) assays

    Quantifying Antigen-Specific Responses or Cell Activation

    Using tetramer technologies, flow cytometry enables characterization and quantification of antigen-specific responses. Using phospho-protein staining, which measures protein phosphorylation at the cellular level, provides insight into the cell signaling pathway after drug treatment to help determine the activation status of the cells.

    Quantifying Rare Cell Populations

    In scenarios, such as measuring minimal residual disease (MRD) or evaluating turnover and bioavailability of CAR-T cells, where the cell(s) of interest have a low frequency, flow cytometry can be useful for quantifying these rare populations. While not as sensitive as other techniques such as polymerase chain reaction (PCR), flow cytometry has the advantage of being able to simultaneously measure other cells on the CAR-T cells.

    Validation of Flow Cytometry Assays

    Biomarkers used in flow cytometry panels should be validated. In clinical studies, all biomarkers must undergo advanced validation to ensure that data are interpretable and reproducible within the expected timeframe, within large patient cohorts, and across different labs. Validation requirements are specific to the stage of drug development and the intended use of the biomarker data.

    It is also essential to eliminate sources of variation that may impact flow cytometric analysis by ensuring the following are consistent across all labs:

    • Sample preparation
    • Sample processing
    • Instrument configuration and settings
    • Data analysis process
    • Standard operating procedure for the assay
    • Operator training

    Example of Flow Cytometry Application: Monitoring T Regulatory Cells

    Regulatory T (Treg) cells are a subpopulation of CD4+ T cells that suppress abnormal or excessive immune responses to self and non-self-antigens to maintain immune homeostasis. In cancer, Treg cells are involved in tumor development and progression by inhibiting antitumor immunity through several immune-suppressive mechanisms. High infiltration by Treg cells is associated with poor survival in various types of cancer. Therefore, strategies for depleting Treg cells and controlling their functions to increase antitumor immune responses are actively being studied in the cancer immunotherapy field.
    Dysregulation in Treg cell type, frequency, or function is implicated in a variety of non-oncologic conditions, including autoimmune diseases. Since Treg cells are versatile and heterogeneous, the ability to identify, quantify, and characterize these cells is critical for elucidating their complex role in immunity and their potential as therapeutic targets. Among different Treg cell types, thymus-derived, natural Treg cells require a panel design and gating strategy that identifies CD4+ CD25+ CD127- Foxp3+ cells.

    Panel Design
    Figure 3. Panel design for flow cytometry panel for Tregs
    Sample Gating Strategy
    Figure 4. Sample gating strategy for flow cytometry panel for Tregs

    Once the panel design and gating strategy have been defined, the assay must be validated to demonstrate that it is fit for purpose within the context of use, including intra-assay, inter-assay, inter-operator variability as shown in Figure 4. Sample aging and staining stability might also be included to determine the cutoff for sample testing and sample acquisition, respectively.

    Figure 5. Intra-assay, inter-assay, inter-operator results on 3 different donors (#1, #2, #3). All results were within the acceptance criteria defined for the fit-for-purpose assay.

    Key takeaways

    Flow cytometry is a vital tool for biomarker-driven clinical trials. Its high flexibility and customizability optimize the amount of data acquired from each sample, generating insights that help accelerate biomarker identification and drug development. While flow cytometry analysis can provide rich data sets that shed light on biological events at single-cell resolution, assay development, validation, and implementation can be complex. Partnering with a specialty lab provider or contract research organization with experience across the full range of flow cytometry applications can help researchers extract high-quality data from every sample.

    Discover how Precision for Medicine supports researchers in obtaining therapeutic insights through flow cytometry.


    • Laura Lozzo, PhD

      Dr. Laura Lozza is Senior Director for Cell Biology at Precision for Medicine. She has long-standing expertise in immune monitoring and immune assay development with a particular focus on flow cytometry assays. Her focused on human immunology, including characterizing the regulatory activities of CD4 T cells, as well as analyzing the response of human dendritic cells in tuberculosis disease and BCG vaccination. She was a leader in establishing Precision’s Cell Biology Lab in Berlin which supports assay development and validation utilizing flow cytometry as well as other cell biology technologies.

    Related Posts

    High-Quality Biospecimens in Therapeutic & Diagnostic Development: A Comprehensive Guide from Concept to Cloud

    Amanda W., Robert S.

    Aug 16, '23 · 9 min. read

    Choosing the Optimal Sample Type for Flow Cytometry: Key Considerations and Case Studies

    Angelina B., Deborah P.

    Jun 22, '23 · 6 min. read

    Methods for a Comprehensive Characterization of the Tumor Microenvironment

    Jie Yang PhD

    Eva R., Jesus G., Jie Y.

    Jun 12, '23 · 7 min. read

    Moving from Exploratory to Clinical Flow Cytometry Assays: 3 Critical Considerations

    Deborah Phippard, PhD

    May 31, '23 · 4 min. read

    Precision for Medicine is part of the Precision Medicine Group, an integrated team of experts that extends Precision for Medicine’s therapeutic development capabilities beyond approval and into launch strategies, marketing communication, and payer insights. As one company, the Precision Medicine Group helps pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.

    Visit the website
    Clinical Trial Services
    • Overview
    • Global Clinical Trial Support
    • Clinical Trial Management
    • Clinical Development Strategy
    • Clinical Trial Design
    • Biostatistics
    • Clinical Sample Management
    • Clinical Research Organization
    Specialty Lab Services
    • Overview
    • Immune Monitoring
    • Flow Cytometry
    • Genomics
    • Tissue & Liquid Biopsy
    • Bioanalytical Testing
    • Cytokine Analysis
    • Biospecimens
    • Sample Processing
    • Global Specimen Transport & Biostorage
    • Contract Research Organization
    • Bioanalysis
    • Neutralizing Antibody (NAb) Assays
    • PBMC Processing
    Data Sciences
    • Overview
    • Biostatistics
    • Clinical Data Management
    • Biometrics
    • QuartzBio
    • Virtual Sample Inventory Management
    Therapeutic Expertise
    • Overview
    • Preclinical Development
    • Early Phase Trials (I-IIa)
    • Late Phase Trials (IIb-III)
    • Oncology and Immuno-Oncology
    • Rare & Orphan Disease
    • Cell & Gene Therapy
    • Neurology
    • COVID-19
    • Autoimmune & Allergy
    • Pediatric
    • Companion Diagnostics
    About Us
    • Our Passion
    • Meet Our People
    • Careers
    • ESG Policy
    • Regulatory Information

    News & Insights
    • Publications
    • Case Studies
    • Thought Leadership
    • News
    • Events
    © 2023 Precision Medicine Group, LLC. All rights reserved. Privacy Policy    GDPR